Month: March 2021

The rates of self-harm are rising, and while asking for help is often the first step to feeling better, it’s a topic we struggle to talk about. Today, Samaritans are calling on the government to prioritise support for people who self-harm We want to talk about self-harm. We know people struggle to talk about self-harm,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Wearing a mask to protect against transmission of COVID-19 does not decrease oxygen saturation, according to a new study. Oxygen saturation did not decline in more than 200 mask-wearing individuals attending an asthma and allergy clinic, regardless of the type of
0 Comments
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first
0 Comments
Johnson & Johnson Coronavirus vaccine illustration Dado Ruvic | Reuters An advisory panel to the Centers for Disease Control and Prevention voted unanimously Sunday to recommend the use of Johnson & Johnson‘s one-shot Covid-19 vaccine as the federal government prepares to ship out millions of doses this week. Once CDC Director Dr. Rochelle Walensky accepts
0 Comments
Today, the U.S. Food and Drug Administration approved Nulibry (fosdenopterin) for injection to reduce the risk of death due to Molybdenum Cofactor Deficiency Type A, a rare, genetic,  metabolic disorder that typically presents in the first few days of life, causing intractable seizures, brain injury and death. Today’s action marks the first FDA approval for
0 Comments